Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Tue, 02nd Jun 2020 12:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Novacyt SA - clinical diagnostics - Says sales of Covid-19 tests totalling EUR135 million at June 1, including EUR45 million already received and forward orders worth an additional EUR90 million. Novacyt says it is selling testing kits to more than 130 countries and wins Zimbabwe contract to supply 1.5 million tests.

----------

Concepta PLC - pregnancy testing and fertility tracking - Reports cost savings made as a result of manufacturing of myLotus fertility tracking product being outsourced. Says in early stages of commercial rollout of myLotus, but announces plans for digital campaign in June.

----------

Hemogenyx Pharmaceuticals PLC - blood disease treatment - Extends development deal with an unnamed global pharmaceutical company due to Covid-19. Partnership to develop CDX antibody candidate extended by three months to complete work.

----------

ValiRx PLC - cancer treatment - To work with Oncolytika Ltd and Black Cat Bio Ltd to explore use of VAL201 in a combination treatment for severe SARS-Cov2 sufferers. ValiRx cautions no guarantee collaboration will result in licensing income.

----------

PureTech Health PLC - biotherapeutics - Says founding entity Gelasis receives approval to market Plenity weight loss treatment in Europe.

----------

Braveheart Investment Group PLC - investment company - Says 80% owned Kirkstall Ltd partnering with Animal Free Research UK, researchers awarding grants to scientists who use techniques to replace use of animals in trials. Says Animal Free Research panel awards outlines projects that will use Kirkstall's Quasi Vivo system in Covid-19 research.

----------

Witan Investment Trust PLC - investor - Says performance so far in 2020 hurt by Covid-19 volatility, with total return at negative 17%, underperforming benchmark which gained 5%. Says UK stocks particularly hit, losing 19% in the period to end of May.

----------

Rambler Metals & Mining PLC - copper and gold producer - Enters into short-term financing agreement with Aether Real Assets Co Investment for GBP1.0 million unsecured loan carrying 10% annual interest, maturing October 5.

----------

Volga Gas PLC - oil and has exploration and production - Says average May production came in an 3,372 barrels of oil equivalent per day, up 45% month-on-month. Adds average price hurt by devaluation of Russian ruble and wider oil price drop.

----------

Ascent Resources PLC - natural resources - Says Slovenian environmental agency has announced Ascent's joint-venture partner Geoenergo doo needs impact assessment before working on PG-10 and PG-11A wells.

----------

Clipper Logistics PLC - logistics - Expects to report full-year earnings before interest, taxes and amortisation of roughly GBP24.0 million, a 19% rise. Reports boosted levels of activity from new and existing customers following initial Covid-19 disruption. Expects EBITA in financial 2021 to beat company-compiled consensus of GBP25.8 million.

----------

Hargreaves Services PLC - industrial and property services - To halt all coal mining operations by July 2020, but will incur GBP3.7 million exceptional cost for year ended May 31, 2020 as a result. Says no material disruption from Covid-19 besides in Property business, where work at a residential site near Edinburgh was suspended.

----------

Quartix Holdings PLC - vehicle tracking - Says trading during the four months to April 30 was stronger year-on-year. Does report however that new fleet installations fell 60% year-on-year in April and 25% annually in May, despite slight rebound as lockdowns eased. Says no material impact on subscription base as a result of Covid-19. Adds pandemic is unlikely to have material impact on profit and cash flow for first half of 2020.

----------

Zotefoams PLC - foam products maker - Maintained operations in April and May, despite challenging demand conditions. Expects trading in the second quarter to be in line with board expectations and forecasts stronger second half.

----------

Water Intelligence PLC - water leak detection - Reacquires San Jose, California franchise to sit within American Leak Detection subsidiary. Allows company to have corporate base in Silicon Valley, offering chance to build on "strong" research and development relationships.

----------

Gusbourne PLC - sparkling wine maker - Says 2020 started strongly but distribution channels hit by Covid-19 since March, though online demand has increased. Winery and vineyards continued production through lockdown, but company has furloughed staff, particularly in sales team. Enters into GBP10.5 million facility with lender PNC Financial Services UK Ltd. Gusbourne says new agreement will refinance existing debts.

----------

Blancco Technology Group PLC - data erasure - Enters in master service agreement to provide Aon Group Co with device diagnostics technology.

----------

Gaming Realms PLC - mobile games - Says licensing revenue continued to grow, surging 80% year-on-year between April and May. Adds revenue helped by new licensing partners like 888casino.com, Sky Betting & Gaming and Draft Kings. Expects earnings before interest, taxes, depreciation and amortisation for 2020 to be significantly ahead of market expectations.

----------

WANdisco PLC - Data and AI - Says it has secured reseller agreement with "large global systems integrator". Reports customer will have access to WANdisco's suite of solutions.

----------

Boku Inc - mobile payments platform - Reports identity services now available in more than 50 countries.

----------

Toople PLC - telecoms - Reports recently-acquired subsidiary Direct Market Services Ltd wins pact to provide IT services to Carluccio's restaurant group.

----------

Iconic Labs PLC - media business - To issue 500.0 million new shares under first tranche of convertible bonds agreement with lender.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
20 Jun 2019 09:54

ValiRx secures 'substantial amendment' to VAL201 clinical trials

(Sharecast News) - Clinical stage biotechnology company ValiRx updated the market on 'VAL201' on Thursday, confirming that, based on clinical results, a "substantial amendment" to the clinical trial protocol had received regulatory approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the research ethics committee.

Read more
13 Jun 2019 11:07

ValiRx Subscription Raises GBP300,000 For Drug Trial And Development (ALLISS)

(Alliance News) - ValiRx PLC on Thursday said it raised GBP300,000 via subscription for working capital and to progress the clinical trial of its VALL201 cancer drug.Shares in ValiRx a 31%

Read more
10 Jun 2019 09:50

ValiRx In Discussions With Investor To End Subscription Agreement (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Monday confirmed it is in advanced discussions with European High Growth Opportunities SF to terminate a subscription agreement.Shares in the clinical

Read more
5 Jun 2019 10:54

ValiRx Convertible Bond Talks In Advanced Stage; Plans Open Offer (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Wednesday said it is in advanced discussions with European High Growth Opportunities SF to enter a new convertible bond facility and is planning an open in a

Read more
31 May 2019 12:04

ValiRx Extends Talks With Investor Over New Convertible Bond (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Friday said it has extended the deadline to enter into a new convertible bond with European High Growth Opportunities SF to July 1.The cancer life was

Read more
29 May 2019 10:41

ValiRx Annual Loss Widens On Higher Costs And Fair Value Losses

LONDON (Alliance News) - ValiRx PLC on Wednesday reported a widened annual loss due to higher costs and losses on the fair value of financial assets.For 2018 the life sciences company, on a

Read more
29 May 2019 10:19

ValiRx losses widen as it continues to progress drug development

(Sharecast News) - Life science company ValiRx reported a loss before income tax of £4.83m in its final results on Wednesday, widening from the £3.55m loss it posted a year earlier.

Read more
2 May 2019 15:21

ValiRx Partners With Alpha Blue Ocean And Buys IP Assets Of FIT Bio

LONDON (Alliance News) - ValiRx PLC on Thursday said it has agreed to acquire the IP assets of FIT Bio for EUR5,000 and establish a genetic therapeutic and diagnostic-based joint venture with Blue

Read more
2 May 2019 09:51

ValiRx acquires IP of failed firm FIT Biotech, forms joint venture

(Sharecast News) - Clinical stage biotechnology company ValiRx announced the acquisition of the global granted patents and intellectual property assets of FIT Biotech for a nominal sum on Thursday.

Read more
26 Apr 2019 14:54

ValiRx To Raise GBP1 Million Under Deal With European High Growth (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Friday said it has entered into a GBP1.3 million subscription agreement with European High Growth Opportunities SF.The stock was trading 17% lower on

Read more
26 Mar 2019 10:22

ValiRx Notes ValiSeek Co-Financing Deals For VAL401 Cancer Drug

LONDON (Alliance News) - Biotechnology firm ValiRx PLC on Tuesday said ValiSeek has secured letters of intent from two companies to co-finance the development of cancer drug VAL401.Shares a

Read more
21 Mar 2019 09:53

ValiRx Notes Encouraging Performance Of VAL201 In Cancer Trial

LONDON (Alliance News) - ValiRx PLC on Thursday said an interim inspection of its VAL201 early phase cancer trial shows the drug is performing as predicted.Shares in ValiRx were up 13% at a

Read more
21 Feb 2019 12:46

ValiRx Raises GBP500,000 Through Placing To Advance Clinical Trials (ALLISS)

LONDON (Alliance News) - ValiRx PLC on Thursday raised GBP500,000 through a share placing to expand its clinical trial of VAL201, as well as the VAL301 and VAL101 programmes.ValiRx issued a

Read more
31 Jan 2019 13:37

ValiRx Secures Patent For VAL301 Compound In Russia And China

LONDON (Alliance News) - ValiRx PLC on Thursday said it has been granted a patent allowance for its therapeutic compound VAL301 in both Russia and China.The clinical stage biotechnology has

Read more
31 Jan 2019 10:08

ValiRx allowed patents for VAL401 in Russia and China

(Sharecast News) - Clinical-stage biotechnology company ValiRx announced on Thursday that the patent offices of Russia and China had both granted a patent allowance for its pre-clinical therapeutic compound, VAL301, subject to payment of the relevant fees.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.